Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

INVA 11.15 -0.20 (-1.76%)
price chart
Form 8-K Innoviva, Inc. For: May 24
On May 24, 2016, GlaxoSmithKline plc (“GSK”) and Innoviva, Inc. distributed a press release announcing headline data from the Salford Lung Study (“SLS”) of RELVAR� ELLIPTA� 100/25mcg (fluticasone furoate/vilanterol or “FF/VI”) in Chronic Obstructive ...
Innoviva hails progress with lung disease treatment  Proactive Investors USA & Canada
Innoviva, GlaxoSmithKline Drug Shows Statistically Significant Reduction In ...  Sonoran Weekly Review
Is it Time to Cash in Profits on Innoviva, Inc. (:INVA)
Innoviva, Inc. (:INVA) stock has moved in an upward direction over the past week, yielding nice gains for investors.
Tech Stocks in Concentration: Net Element, Inc. (NASDAQ:NETE) Innoviva Inc ...
Net Element, Inc. (NASDAQ:NETE) initiated the shares trading at $0.279 and showed positive change of +1.852% while the stock's final trade was registered at $ 0.275.
Worth Watching Stock: Innoviva, Inc. (INVA)
Innoviva, Inc. (INVA) is expected to report Q1 earnings after market close (confirmed) on Thursday 04/28/2016. The company operates in the Application Software industry.
Innoviva meets 1Q profit forecasts  Money Morning
Innoviva: On Track To Buy Back The Whole Company
I have already reviewed the performance of GSK's (NYSE:GSK) new respiratory drugs in another article, so this one will focus on the issues specific to its development partner Innoviva (NASDAQ:INVA) (formerly called Theravance). Innoviva ended 2015 with ...
Theravance (THRX) Changes Name, Ticker to Innoviva (INVA)
Theravance, Inc. (NASDAQ: THRX) announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva's new name, the company has also unveiled a new corporate identity and website, available at www.
Innoviva Breaks Below 200-Day Moving Average - Notable for INVA
In trading on Thursday, shares of Innoviva Inc (Symbol: INVA) crossed below their 200 day moving average of $11.03, changing hands as low as $10.69 per share.
Noteworthy Buzzers: Innoviva, Inc. (NASDAQ:INVA) , Applied DNA Sciences Inc ...
On 5/13/2016, Innoviva, Inc. (NASDAQ:INVA) ended trading session lower at $10.70 with -0.47%. The company traded a volume of 827.63 thousand shares as comparison to average volume of 680.31 thousand shares.
Innoviva Inc (INVA) Rating Increased to Buy at Zacks Investment Research
Innoviva logo Innoviva Inc (NASDAQ:INVA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Wednesday, Market Beat.
Innoviva Inc (INVA) Stock Rating Lowered by Zacks Investment Research
Innoviva Inc (NASDAQ:INVA) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, Marketbeat reports.